Top rated depression clinical trials in New York, New York
Here are the top 10 medical studies for depression in New York, New York
Popular filter options for depression new-york trials
Phase 3 Clinical Trials
View 99 phase 3 medical studies.
Lumateperone for Depression
Recruiting1 awardPhase 3
Brooklyn, New York
This trial is testing a new drug for people with depression who haven't responded to other treatments. It's a double-blind study, which means that neither the patients nor the researchers will know who's receiving the real drug or the placebo.
Serotonin Reuptake Inhibitor
Venlafaxine HCl ER +1 More for Depression
Recruiting2 awardsPhase 3
New York, New York
This trial will show whether interpersonal psychotherapy or a serotonin reuptake inhibitor is more acceptable to patients with breast cancer and depression, and whether one treatment is superior in reducing depression symptoms and inflammation.
Investigational Drug for Bipolar Depression
Recruiting1 awardPhase 3
Staten Island, New York
This trial is testing whether an investigational drug is effective and safe for treating bipolar I depression. The trial will be conducted in the US, Europe, Latin America, and Japan, with both male and female participants ages 18-65. Participation will last approximately 10 weeks.
Clinical Trials With No Placebo
View 99 medical studies that do not have a placebo group.
Behavioral Intervention
Isolation Conditions for Stress and Resilience
Recruiting1 award5 criteria
Philadelphia, Pennsylvania
This trial looks at how well people adapt to living in a isolated, controlled environment. It will look at how work, monotony, social and physical isolation affects people's stress resiliency and well-being.
Behavioural Intervention
Behavioral Activation and Exposure Therapy for Anxiety and Depression in Youth
Recruiting1 award10 criteria
Piscataway, New Jersey
This trial will compare the effectiveness of different psychological treatments for anxiety and depression in youth, as well as how well each treatment works to change specific aspects related to the disorders.
Behavioral Intervention
Problem Adaptation Therapy for Cognitive Impairment and Depression
Recruiting1 award
New York, New York
This trial will compare two therapies for people with mild cognitive impairment: Problem Adaptation Therapy (PATH) and Supportive Therapy (ST). The goal is to see which therapy improves cognitive, affective, and functional outcomes more.
View More Depression New-york Trials
See another 80 medical studies focused on depression new-york.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.